Topical Atropine for Myopia Control: A Review
Klinische Monatsblätter für Augenheilkunde · 2024-10 · 241 (10) · 1134-1139
DOI: 10.1055/a-2307-0363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, online erschienen am 27.05.2024. Verfasst von Navid Farassat. Beteiligte Einrichtung: Medical Center, Eye Center, University Freiburg, Germany. Hauptthemen laut MEDLINE: Atropine, Myopia, Mydriatics, Ophthalmic Solutions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Over the past decade, atropine has emerged as an effective intervention for preventing myopia in children. Multiple randomized controlled trials, mainly from Asia, have demonstrated the safety and efficacy of topical atropine for myopia control. Both efficacy and side effects exhibit a positive dose-response relationship. This review focuses on new data from studies with predominantly white populations, ethnicity-dependent differences in efficacy and side effects, and primary prevention of incident myopia with atropine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Center, Eye Center, University Freiburg, Germany.
Zitieren
APA
Farassat, N. (2024). Topical Atropine for Myopia Control: A Review. Klinische Monatsblätter für Augenheilkunde, 241(10), 1134-1139. https://doi.org/10.1055/a-2307-0363
Vancouver
Farassat N. Topical Atropine for Myopia Control: A Review. Klinische Monatsblätter für Augenheilkunde. 2024;241(10):1134-1139. doi:10.1055/a-2307-0363
BibTeX
@article{Farassat2024,
author = {Farassat, Navid},
title = {Topical Atropine for Myopia Control: A Review},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {10},
pages = {1134--1139},
doi = {10.1055/a-2307-0363}
}
EUVIMED